Clinical trial
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances
NCT00353860 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00353860 |
|---|---|
| Title | Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances |
| Official title | Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Role of Preparative Regimen and T Cell Dose in Graft Rejection and GVHD |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Immunosuppression, Leukemia |
| Intervention type | Device |
| Interventions | SOLEX 300i Stem Cell Selection |
| Enrollment | 70 |
| Start date | Jan 23, 2002 |
| Primary completion | Nov 29, 2007 |
| Completion | Nov 29, 2007 |
| First posted | Jul 19, 2006 |
| Last update posted | Dec 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: